Ovarian Cancer’s Hidden Threat? It’s in the Fluid, Not the TumorResearch reveals how ascites in ovarian cancer disrupts immunity, hindering tumor defense but offers potential treatment solutions.
Corcept’s New Cancer Pill Boosts Survival for Drug-Resistant PatientsCorcept's Relacorilant shows promise in treating platinum-resistant ovarian cancer, extending survival by 4.5 months in trials.
Ovarian Cancer: Early Detection and Prevention StrategiesOvarian cancer, the deadliest gynecological cancer, is often diagnosed late; early detection can significantly improve survival rates.
Must-Reads
1
Trump Claims Epstein 'Stole' Young Women from Mar-a-Lago Spa
LATEST
2
Say Hello to Your New Beauty Buddy: AI-Powered Kiosks Hit GS25 Stores!
LATEST
3
New Task Force Takes Aim at Stock Manipulators: A Game Changer for Investors!
LATEST
4
COP30 Chaos: Will Brazil's Soaring Hotel Prices Keep Poor Nations Out of Climate Talks?
LATEST
5
Is Tesla Behind LG Energy's Massive Battery Supply Contract?
Ovarian Cancer’s Hidden Threat? It’s in the Fluid, Not the Tumor Research reveals how ascites in ovarian cancer disrupts immunity, hindering tumor defense but offers potential treatment solutions.
Corcept’s New Cancer Pill Boosts Survival for Drug-Resistant Patients Corcept's Relacorilant shows promise in treating platinum-resistant ovarian cancer, extending survival by 4.5 months in trials.
Ovarian Cancer: Early Detection and Prevention Strategies Ovarian cancer, the deadliest gynecological cancer, is often diagnosed late; early detection can significantly improve survival rates.
Hot Topics